WG

Wanlian Guangsheng

Description

Wanlian Guangsheng is an investment firm.

Investor Profile

Wanlian Guangsheng has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Biotechnology, Health Care.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
  • Optical Communication
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wanlian Guangsheng frequently co-invest with?

YIMI
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Guangdong Technology Financial Group
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 1
Wanlian Tianze
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
GK
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
PI
Asia, Guangdong, China, Panyu
Co-Investments: 1
Chuangyu Investment Management
Asia, Guangdong, China, Huangpu
Co-Investments: 1
BOC & Utrust Private Equity Fund Management
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
KC
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Addor Capital
Asia, Jiangsu, China, Nanjing
Co-Investments: 1

What are some of recent deals done by Wanlian Guangsheng?

Liobate

Guangzhou, Guangdong, China

Liobate specializes in designing, creating, and selling thin-film lithium niobate modulator chips and related optical interconnect devices.

ManufacturingOptical CommunicationSemiconductor
Series AFeb 28, 2025
Amount Raised: $13,729,097
Bostal Drug Delivery

Guangzhou, Guangdong, China

Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems.

BiotechnologyHealth CareLife ScienceManufacturingPharmaceutical
Series BAug 19, 2023